Revolution Medicines

-$0.96 (-3.32%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RVMD and other ETFs, options, and stocks.

About RVMD

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway.

CEO
Mark A. Goldsmith
Employees
125
Headquarters
Redwood City, California
Founded
2015

RVMD Key Statistics

Market Cap
2.31B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
451.10K
High Today
$29.29
Low Today
$27.88
Open Price
$28.98
Volume
259.23K
52 Week High
$56.18
52 Week Low
$21.17

RVMD Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure